Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats
Samar A. Antar, Walied Abdo, Reda S. Taha, Amira E. Farage, Laila E. El-Moselhy, Mohamed E. Amer, Ahmed S. Abdel Monsef, Amer M. Abdel Hamid, Emadeldin M. Kamel, Ahmad Ahmeda, Ayman M. Mahmoud
Topics & Concepts
Oxidative stressDiabetic nephropathyTelmisartanMedicineDiabetes mellitusEndocrinologyKidneyInternal medicineMalondialdehydeStreptozotocinNephropathyDownregulation and upregulationPharmacologyNitric oxideChemistryBiochemistryBlood pressureGeneEicosanoids and Hypertension PharmacologyChronic Kidney Disease and DiabetesAdvanced Glycation End Products research